Crossmark

Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice

Published Online: 2019-07-16

Published Print: 2019-12

Authors

Kuroshima, Shinichiro https://orcid.org/0000-0001-9891-9987
Nakajima, Kazunori

Sasaki, Muneteru

I, Takashi

Sumita, Yoshinori

Asahara, Takayuki

Asahina, Izumi

Sawase, Takashi
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (25870523, 15K11258, 18H02994, 16K20510)
License Information

Text and Data Mining valid from 2019-07-16

Version of Record valid from 2019-07-16
More Information

Article History

Received: 30 October 2018

Revised: 14 May 2019

Accepted: 19 June 2019

First Online: 16 July 2019

Ethics approval and consent to participate

: Animal care and experimental procedures were performed in accordance with the Guidelines for Animal Experimentation of Nagasaki University, with approval from the Ethics Committee for Animal Research (Approval No. 1708241404-2 and 1610181345-5).

: Not applicable

: The authors declare that they have no competing interests.

Document is current